Eve & Co Announces Operating Highlights and Financial Results for the Three Months Ended March 31, 2021
May 31, 2021 17:08 ET | Source: Eve & Co Incorporated Eve & Co Incorporated Strathroy, Ontario, CANADA
STRATHROY, Ontario, May 31, 2021 (GLOBE NEWSWIRE) Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce its operating highlights and financial results for the quarter ended March 31, 2021.
The financial statements and management’s discussion and analysis for such period are available on the System for Electronic Document Analysis and Retrieval ( SEDAR ) at www.sedar.com and on Eve & Co s website at www.evecannabis.ca.
Operating Highlights
The Company recognized gross sales of cannabis to the adult-use and wholesale markets of $2.47 million as compared to $0.47 million for the quarter ended March 31, 2020, representing an increase of 430%;
Eve & Co Announces CAD$1M Private Financing
December 30, 2020 17:36 ET | Source: Eve & Co Incorporated Eve & Co Incorporated Strathroy, Ontario, CANADA
STRATHROY, Ontario, Dec. 30, 2020 (GLOBE NEWSWIRE) Eve & Co. Incorporated (TSXV: EVE) (OTCQX: EEVVF) (the “Company” or “Eve & Co”) announces that its wholly-owned subsidiary Natural MedCo Ltd (“NMC”) has entered into a CAD$1M financing loan with a private consortium of lenders (the “CAD$1M financing” or the “Loan”).
The CAD$1M financing has a two-year term and is to be received in two equal tranches of CAD$500,000. The first CAD$500,000 tranche has been received – net of issuance costs of approximately CAD$29,000 – and bears interest – payable monthly – at 15% per annum for the first year and 11% per annum for the second year. Monthly repayments of principal and interest can only be made during the second year of the term. The principal outstanding